Detalles de la búsqueda
1.
Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies.
Respir Res
; 20(1): 135, 2019 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31266489
2.
Efficacy of Indacaterol/Glycopyrrolate in Patients with COPD by Airway Reversibility at Baseline: A Pooled Analysis of the FLIGHT1 and FLIGHT2 12-Week Studies.
COPD
; 16(2): 133-139, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31242792
3.
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Lung
; 195(6): 739-747, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28993871
4.
Implementing Digital Technologies in Clinical Trials: Lessons Learned.
Innov Clin Neurosci
; 19(4-6): 65-69, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35958972
5.
Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD.
NPJ Prim Care Respir Med
; 31(1): 43, 2021 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34620878
6.
Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD.
Int J Chron Obstruct Pulmon Dis
; 16: 1061-1073, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33907393
7.
Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
Int J Chron Obstruct Pulmon Dis
; 16: 945-955, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33880019
8.
Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD.
Pulm Ther
; 7(2): 503-516, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34232493
9.
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.
Int J Chron Obstruct Pulmon Dis
; 16: 865-875, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33833507
10.
The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Pulm Pharmacol Ther
; 23(4): 235-56, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20381629
11.
In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®.
Pulm Ther
; 6(2): 289-301, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32809156
12.
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies.
Int J Chron Obstruct Pulmon Dis
; 15: 745-754, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32341641
13.
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
Int J Chron Obstruct Pulmon Dis
; 15: 995-1004, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32440111
14.
The Effect of Metabolic Syndrome Status on Lung Function and Patient-reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
Chronic Obstr Pulm Dis
; 7(4): 315-326, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822528
15.
Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4.
Int J Chron Obstruct Pulmon Dis
; 14: 27-37, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30587959
16.
Effect of smoking status on lung function, patient-reported outcomes, and safety among patients with COPD treated with indacaterol/glycopyrrolate: Pooled analysis of the FLIGHT1 and FLIGHT2 studies.
Respir Med
; 155: 113-120, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31344660
17.
Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies.
Int J Chron Obstruct Pulmon Dis
; 14: 461-470, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30863047
18.
Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors.
Chronic Obstr Pulm Dis
; 6(1): 86-99, 2018 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30775427
19.
Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD.
Int J Chron Obstruct Pulmon Dis
; 13: 2917-2929, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30275690
20.
The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers.
Chronic Obstr Pulm Dis
; 5(2): 111-123, 2018 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30374449